Paxman
62,2
SEK
-3,72 %
Mindre end 1K følgere
PAX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Finansielt overblik og estimater
Ownership
-3,72%
-10,63%
-5,18%
-3,72%
+19,62%
+79,77%
+13,92%
+69,02%
+470,64%
Paxman is active in scalp cooling, which is used for patients being treated for chemotherapy. The company's product Paxman Scalp Cooler is used to minimize the patient's hair loss during treatment. The Scalp Cooler is a stand-alone, mobile, and electrically powered cooling unit that cools the patient's scalp via a cooling cap. The company was founded in 1996 and has its headquarter in Karlshamn.
Læs mereMarkedsværdi
1,18 mia. SEK
Aktieomsætning
7,6 mio. SEK
Omsætning
253,01 mio.
EBIT %
13,24 %
P/E
29,48
Udbytteafkast, %
-
Finanskalender
16.5
2025
Generalforsamling '25
16.5
2025
Delårsrapport Q1'25
20.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
See Redeye's interview with CEO Richard Paxman
Paxman’s Record-Breaking Streak Continues!
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools